Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: JMIR Cancer

Date Submitted: Apr 27, 2022
Date Accepted: Jul 14, 2022

The final, peer-reviewed published version of this preprint can be found here:

Characterizing the Patient Journey in Multiple Myeloma: Qualitative Review

Lyall M, Crawford R, Bell T, Mamolo C, Neuhof A, Levy C, Heyes A

Characterizing the Patient Journey in Multiple Myeloma: Qualitative Review

JMIR Cancer 2022;8(3):e39068

DOI: 10.2196/39068

PMID: 36136395

PMCID: 9539647

Characterizing the Patient Journey in Multiple Myeloma: A Patient Perspective

  • Matthew Lyall; 
  • Rebecca Crawford; 
  • Timothy Bell; 
  • Carla Mamolo; 
  • Alexander Neuhof; 
  • Courtney Levy; 
  • Anne Heyes

ABSTRACT

Background:

Current published information on the patient perspective and treatment of multiple myeloma (MM) is limited, making it difficult to gain insights into patient needs regarding the condition.

Objective:

In this review, a combined research methods approach (ie, the review of published literature and social media posts) was undertaken to provide insight into patients’ perspectives on the impact of MM and its treatment.

Methods:

Targeted searches of PubMed and PsycINFO were conducted and, in parallel, patient-reported information (PRI) derived from social media posts from 6 patient advocacy websites and YouTube was searched.

Results:

A total of 27 articles and 138 posts were included (PRI included information from 76 individuals), and results from both sources found that patients experience a variety of symptoms and treatment side effects that affect areas of health-related quality of life (HRQoL), including physical functioning; emotional, psychological, and social well-being; the ability to work; and relationships. Patients valued involvement in treatment decision-making and preference for treatments was strongest when associated with increased survival. Caregiver HRQoL is affected in several areas, including emotional-, role-, social-, and work-related aspects of life.

Conclusions:

The combination of published literature and PRI provides valuable and rich detail on the patient experience and perceptions of MM and its treatment. The data highlighted that patients’ HRQoL is impeded not only by the disease, but also by the treatment-related side effects; there is a range of unmet needs and areas for further research to improve the understanding of the journey for patients with MM.


 Citation

Please cite as:

Lyall M, Crawford R, Bell T, Mamolo C, Neuhof A, Levy C, Heyes A

Characterizing the Patient Journey in Multiple Myeloma: Qualitative Review

JMIR Cancer 2022;8(3):e39068

DOI: 10.2196/39068

PMID: 36136395

PMCID: 9539647

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.